Metabolism Day 2021
The Metabolism Day 2020 was postponed
It was with the greatest disappointment that we had to postpone Metabolism Day 2020 on March 19 due to the ongoing coronavirus pandemic.
We are delighted to inform you that after the postponement of Metabolism Day 2020, Metabolism Day has been rescheduled to March 18, 2021. If in the beginning of 2021 the circumstances continue to prohibit international symposia of that size, we might consider organizing the meeting in an online format.
We appreciate the time that has been committed to Metabolism Day, especially by our speakers and those who submitted abstracts and were due to present posters at the symposium. We extend our thanks to everyone affected for their understanding.
We are hoping that you will be able to join us March 18, 2021 to present your research and discuss the latest science in metabolic diseases and energy control.
Professor Juleen R. Zierath
Professor Birthe Høgh
Vice Executive Director
About Metabolism Day
Metabolism Day brings together researchers within the field of metabolism to discuss the latest science in metabolic diseases and energy control. All researchers with an interest in metabolic research are welcome to attend the event.
The day includes eight invited international speakers, poster sessions and prizes, and concludes with a buffet dinner.
Participation is free of charge, but for catering purposes, registration is required.
|8:30-9:00||Registration, Coffee and set-up of Posters|
|9:00-9:15||Welcome Address||Executive Director, Professor Juleen R. Zierath, CBMR|
The Genetics of Obesity – From genes, to biology, … to clinical practice
Professor Ruth Loos, Icahn School of Medicine at Mount Sinai, USA
Professor Torben Hansen, CBMR
|9:50-10:25||Programming of Cardio-Metabolic Health by Maternal Obesity: A Developing Crisis||Professor Susan Ozanne, University of Cambridge, United Kingdom||Professor Romain Barrès, CBMR|
|10:25-10:50||Posters and Coffee|
|10:50-11:25||Metabolic Control of the Molecular Clock||Professor Joseph Bass, Northwestern University, USA||Associate Professor Zach Gerhart-Hines, CBMR|
|11:25-12:00||The Genetics of Exercise Adherence and Response||Professor Molly S. Bray, University of Texas at Austin, USA||Professor Kei Sakamoto, CBMR|
|12:00-13:00||Posters and Lunch|
|13:00-13:35||A Sociology of One-Carbon Metabolism||Professor Hannah Landecker, University of California, USA||Associate Professor Louise Whiteley, CBMR|
|13:35-14:10||Big Data and Health||
Professor Michael Snyder, Stanford University, USA
|Associate Professor Manimozhiyan Arumugam, CBMR|
|16:10-16:45||The CNS Control of Metabolism||Professor Martin Myers, University of Michigan, USA||Associate Professor Tune H. Pers, CBMR|
|16:45-17:20||Adipose Tissue – Therapeutic target for Diabetes||Professor Philipp Scherer, University of Texas Southwestern, USA||Associate Professor Camilla Schéele, CBMR|
|17:20-17:30||Closing Remarks||Executive Director, Professor Juleen R. Zierath, CBMR|
|17:30-20:00||Buffet Dinner and Poster Prize Ceremony|
Active as both an endocrinologist and investigator, Bass has opened up a new field that is illuminating how molecular clocks control physiology at different times of day, with a broad range of medical implications including new avenues for treating diabetes and obesity.
Work in her laboratory is designed to identify the mechanisms by which timing and quality of energy intake affects weight gain and metabolic health, in particular through intestinal absorption and the gut microbiome.
Dr. Bray also currently leads one of the largest genetic studies of exercise adherence established to date, the Training Interventions and Genetics of Exercise Response (TIGER) study, with a total cohort of more than 3,500 individuals. Dr. Bray's research has included investigations of aerobic fitness and resting and exercise energy expenditure in children and adolescents and clinical studies of morbidly obese adolescents undergoing bariatric surgery.
Hannah Landecker holds a joint appointment in the life and social sciences at UCLA, where she is a Professor in the Department of Sociology, and Director of the Institute for Society and Genetics. The Institute for Society and Genetics is an interdisciplinary unit at UCLA committed to cultivating research and pedagogy at the interface of the life and human sciences, and houses the Human Biology and Society undergraduate major. She also recently helped found the UCLA EpiCenter for interdisciplinary study of the intersection of reproduction, epigenetics, and society, and is its co-director; she is a senior editor of the journal BioSocieties.
Landecker, a historian and sociologist of science, studied cell and developmental biology before going on to receive her PhD in Science and Technology Studies from MIT. She is the author of Culturing Life: How Cells Became Technologies (Harvard UP, 2007), as well as many research articles spanning topics from the development of time-lapse microcinematography to the environmental politics of reproduction. Her current research interests have turned toward the history and social study of metabolism and epigenetics, and this talk is drawn from her current book project, American Metabolism.
Her research focuses on the etiology of obesity, in particular, on the identification of genes and genetic loci contributing to the risk of obesity and related traits. She has been involved in gene-discovery since 2005. With the GIANT (Genetic Investigation of ANTropometric traits) consortium, she has contributed to the majority of large-scale gene-discovery efforts that thus far have revealed more than 1,000 obesity-associated loci. Furthermore, she studies more refined adiposity phenotypes and biomarkers related to body shape and fat distribution to reveal new biology that has not been uncovered by using traditional obesity outcomes.
Besides gene-discovery, Ruth uses epidemiological methods to assess the public health implications of the established loci by examining their predictive value, interaction with lifestyle factors, and their role in precision medicine of common obesity.
The Myers lab studies the mechanisms by which brain circuits contribute to the control of energy balance and metabolic homeostasis, including a major focus on leptin. Recent work also focuses on neural mechanisms that control glucose homeostasis and brainstem circuits that control feeding.
Dr. Myers received the Jerome Conn and Basic Science Research Awards from the University of Michigan, Outstanding Scientific Achievement Awards from The Obesity Society and from the American Diabetes Association, and the Ernst Oppenheimer Award from the Endocrine Society. Dr. Myers directs the University of Michigan diabetes initiative (M-Diabetes) and the Michigan Diabetes Research Center and is the Editor-in-Chief of the journal, Diabetes.
Susan Ozanne is Professor of Developmental Endocrinology in the University of Cambridge Institute of Metabolic Science Metabolic Research Laboratories and the MRC Metabolic Diseases Unit. She is also a Fellow of Churchill College, Cambridge. She obtained a first class honours degree in Biochemistry from the University of Edinburgh, in 1990. She then went to Christ’s College at the University of Cambridge where she obtained her PhD in 1994. Prior to her current appointment she was a British Heart Foundation Senior Fellow.
Her research interests are focused on understanding the mechanistic basis of the relationship between suboptimal early nutrition and risk of diseases such as type 2 diabetes, obesity and cardiovascular disease in later life. Professor Ozanne is the author of over 200 peer-reviewed full papers on the early origins of health and disease and is an elected member of the council of the Society for the Developmental Origins of Health and Disease.
Current efforts in his laboratory are focused on the identification and physiological characterization of novel proteins that serve as potential links between the adipocyte, liver, the pancreatic beta cell and the processes of whole body energy homeostasis, inflammation, cancer and cardiovascular disease.
Scherer has been on the faculty of UT Southwestern Medical Center since 2007 as a member of the Department of Internal Medicine. He holds the Touchstone Distinguished Chair in Diabetes Research and is a member of the Simmons Comprehensive Cancer Center. He was awarded the 2015 Banting Medal for Scientific Achievement from the American Diabetes Association, the 2017 European Association for the Study of Diabetes (EASD) / Novo Nordisk Foundation Diabetes Prize for Excellence and the 2018 Manpei Suzuki Prize in Japan.
Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and multiomics, and one of the major participants of the ENCODE project.
His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor (TF) binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated (e.g. lncRNAs and TF binding sites), and a high diversity of transcription factor binding occurs both between and within species.
He has also combined different state-of–the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of many biotechnology companies, including Excelix, Personalis, SensOmics, Qbio, January, Mirvie and Filtricine.
Participants will receive an abstract book with all abstracts at Metabolism Day.
You are expected to present your poster during Metabolism Day 2021. You will be informed of the timeslot of your presentation in advance.
The size of the poster boards are 115 cm (width) x 160 cm (height) (~45 x 63 inches).